Papillary Thyroid Cancer ICD 10: Diagnosis And Treatment Guidelines
What is Papillary Thyroid Cancer ICD 10?
Papillary thyroid cancer is a type of cancer that starts in the cells of the thyroid gland. It is the most common type of thyroid cancer, accounting for about 80% of all cases. The ICD-10 code for papillary thyroid cancer is C73.9.
Code Information for Papillary Thyroid Cancer ICD 10
The ICD-10 code C73.9 is used to classify papillary thyroid cancer. This code is part of the International Classification of Diseases, which is a system used by healthcare providers to categorize and code diagnoses and procedures.
Diagnostic Related Groups (MS-DRG)
Papillary thyroid cancer is classified under MS-DRG 643 – Endocrine Disorders with MCC (Major Complications or Comorbidities). This DRG categorizes cases where the patient has a major complication or comorbidity related to an endocrine disorder.
Convert to ICD-9 Code
The ICD-9 code for papillary thyroid cancer is 193.0. This code was used prior to the implementation of ICD-10 in the United States.
Code History
The ICD-10 code for papillary thyroid cancer was introduced in 2015 as part of the transition from ICD-9 to ICD-10. This change was made to improve the accuracy and specificity of diagnostic coding.
Approximate Synonyms
Other names for papillary thyroid cancer include papillary adenocarcinoma of thyroid, papillary carcinoma of the thyroid, and thyroid papillary carcinoma. These terms are used interchangeably to describe the same type of cancer.
Clinical Information
Papillary thyroid cancer typically starts as a small lump in the thyroid gland. It is usually slow-growing and may not cause any symptoms in the early stages. As the cancer grows, it may cause symptoms such as neck pain, hoarseness, difficulty swallowing, and swollen lymph nodes.
Causes of Papillary Thyroid Cancer
The exact cause of papillary thyroid cancer is unknown, but several risk factors have been identified. These include a family history of thyroid cancer, exposure to radiation, and certain genetic conditions such as Cowden syndrome and familial adenomatous polyposis.
Symptoms of Papillary Thyroid Cancer
Common symptoms of papillary thyroid cancer include a lump in the neck, hoarseness, difficulty swallowing, and swollen lymph nodes. Some patients may also experience neck pain, shortness of breath, and coughing up blood.
Diagnosis of Papillary Thyroid Cancer
Papillary thyroid cancer is typically diagnosed through a combination of imaging tests, such as ultrasound and CT scans, and a biopsy of the thyroid nodule. Blood tests may also be used to measure levels of thyroid hormones and thyroid-stimulating hormone.
Treatment of Papillary Thyroid Cancer
Treatment for papillary thyroid cancer usually involves surgery to remove the thyroid gland and any affected lymph nodes. In some cases, radioactive iodine therapy may be used to destroy any remaining cancer cells. Other treatments, such as hormone replacement therapy and targeted therapy, may also be recommended.
Conclusion
In conclusion, papillary thyroid cancer is a common type of thyroid cancer that can be effectively treated with surgery, radioactive iodine therapy, and other treatments. Early diagnosis and treatment are key to achieving a good outcome for patients with this type of cancer.
FAQs about Papillary Thyroid Cancer ICD 10:
Q: What is the ICD-10 code for papillary thyroid cancer?
A: The ICD-10 code for papillary thyroid cancer is C73.9.
Q: What are the symptoms of papillary thyroid cancer?
A: Common symptoms of papillary thyroid cancer include a lump in the neck, hoarseness, difficulty swallowing, and swollen lymph nodes.
Q: How is papillary thyroid cancer diagnosed?
A: Papillary thyroid cancer is typically diagnosed through imaging tests, such as ultrasound and CT scans, and a biopsy of the thyroid nodule.
Q: What are the treatment options for papillary thyroid cancer?
A: Treatment for papillary thyroid cancer usually involves surgery, radioactive iodine therapy, hormone replacement therapy, and targeted therapy.
Q: What is the prognosis for patients with papillary thyroid cancer?
A:
